<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types

Patient-Derived Xenograft Models of Colorectal Cancer

Robust, well characterized preclinical models are essential for the advancement of targeted therapies for colorectal cancer. Colon cancer patient-derived xenograft (PDX) models display a true representation of the human genetic and phenotypic heterogeneity seen in patient populations and provide the most accurate approach to predicting an agent’s efficacy prior to entering the clinic. Crown Bioscience has one of the largest collections of Colorectal cancer PDX models, including subcutaneous and orthotopic models to more closely recapitulate the tumor microenvironment. More

Benefits of Crown Bioscience's Colon cancer Patient derived xenograft model research

Our Colorectal cancer Patient-derived xenograft models offer the most translational preclinical model for efficacy screening in Colon cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, Patient derived xenograft reflects the heterogeneity and diversity of the human patient population. Colon cancer PDX model will give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime® Rectal cancer PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER TYPE CANCER SUBTYPE DESCRIPTION # per page
CR0004 Colorectal Cancer ADC Adenocarcinoma of colon, protruded type, moderately differentiated, invaded through intestinal wall to peripheral adipose tissue. Regional LN: paraintestinal LN (1/7). IHC results: HER-1(-), HER-2(-), p53( 50~75%+), p170(-), Ki-67(25~50%+), VEGF(+++), Top-IIa(<25%+), p16(<25%+). CLICK TO VIEW
CR0010 Colorectal Cancer ADC Adenocarcinoma of descending colon, carcinoma in situ, ulcerative type, well-moderately differentiated, tumor mass: 6cm x 4.5cm x 3.5cm. CLICK TO VIEW
CR0012 Colorectal Cancer ADC Adenocarcinoma of rectum, ulcerative type, carcinoma in situ, moderately differentiated, tumor mass: 6cm x 5.5cm x 1.5cm. CLICK TO VIEW
CR0024 Colorectal Cancer ADC Adenocarcinoma, moderately differentiated. CLICK TO VIEW
CR0028 Colorectal Cancer ADC Adenocarcinoma of ascending colon with part of mucinous adenocarcinoma, carcinoma in situ, ulcerative type, moderately differentiated, tumor mass: 7cm x 4.5cm x 2cm. CLICK TO VIEW
CR0029 Colorectal Cancer ADC Carcinoid, protruded type. CLICK TO VIEW
CR0047 Colorectal Cancer ADC Moderately to poorly differentiated adenocarcinoma CLICK TO VIEW
CR0126 Colorectal Cancer Mucinous adenocarcinoma Adenocarcinoma of the rectum with mucinous adenocarcinoma, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 4cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/4). CLICK TO VIEW
CR0133 Colorectal Cancer ADC Moderately differentiated adenocarcinoma CLICK TO VIEW
CR0146 Colorectal Cancer ADC Adenocarcinoma with mucinous carcinoma, moderately-poorly differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 4cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/5). CLICK TO VIEW
CR0150 Colorectal Cancer ADC Adenocarcinoma of cecum, moderately-poorly differentiated, ulcerative type, infiltrating into serosa, tumor mass: 5cm x 5cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (3/6). CLICK TO VIEW
CR0170 Colorectal Cancer ADC Adenocarcinoma of rectum, ulcerative type, moderately-poorly differentiated, infiltrating into deep muscular layer, tumor mass: 4cm x 3cm x 1cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/2). CLICK TO VIEW
CR0193 Colorectal Cancer ADC Adenocarcinoma of colon, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 6.5cm x 4.5cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (0/9). CLICK TO VIEW
CR0196 Colorectal Cancer ADC Adenocarcinoma of the rectum, moderately differentiated, ulcerative type, infiltrating into serosa, tumor mass: 3.5cm x 3cm x 0.8cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN (8/10). CLICK TO VIEW
CR0205 Colorectal Cancer ADC 1.Adenocarcinoma of transverse colon, moderately-poorly differentiated, infiltrative type, invaded serosa, tumor mass: 8cm x 7cm x 1.5cm. No malignant cells adjacent to both stump. Regional LN: mesenteric LN(1/7). 2.Adenocarcinoma of duodenal papilla, moderately-poorly differentiated, invaded submucosa, tumor mass: 2.4cm x 1.2cm x 1cm. No malignant cells adjacent to both stump and pancreatic stump. Regional LN: parahepatic artery LN (0/2), LN surround common hepatic duct (0/3), greater curvature LN (0/2), parapyloric LN (0/8), parapancreatic LN (0/1). CLICK TO VIEW
CR0231 Colorectal Cancer ADC Moderately differentiated adenocarcinoma with part of mucinous adenocarcinoma CLICK TO VIEW
CR0245 Colorectal Cancer ADC, Mucinous Mucinous adenocarcinoma CLICK TO VIEW
CR0455 Colorectal Cancer ADC Adenocarcinoma of colon, poorly differentiated. CLICK TO VIEW
CR0460 Colorectal Cancer ADC Metastatic adenocarcinoma in liver. Chronic cholecystitis. Regional LN: LN of external gallbladder wall (2/2). CLICK TO VIEW
CR0560 Colorectal Cancer ADC Moderately to poorly differentiated adenocarcinoma CLICK TO VIEW
CR0588 Colorectal Cancer ADC Moderately differentiated adenocarcinoma CLICK TO VIEW
CR10901 Colorectal Cancer NA Colon Carcinoma. C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
CR11370 Colorectal Cancer NA NA CLICK TO VIEW
CR11372 Colorectal Cancer NA Small Intestine Carcinoma, FS: favor adenocarcinoma. CLICK TO VIEW
CR11374 Colorectal Cancer ADC N/A CLICK TO VIEW
CR11377 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1197 Colorectal Cancer ADC Metastatic adenocarcinoma to lung, consider metastatic intestinal adenocarcinoma. Cubical and columnar tumor cells form irregular adenoid structures and has an infiltrative growth pattern. Pools of mucin may be seen. Regional LN: parabronchial LN (0/2), the eleventh group LN (0/3). CLICK TO VIEW
CR1207 Colorectal Cancer ADC Adenocarcinoma of right lung, moderately differentiated, tumor mass: 4cm x 4cm x 3cm. CLICK TO VIEW
CR1231 Colorectal Cancer ADC Metastatic adenocarcinoma of LN of porta hepatis. The tumor forms irregular glandular structures and has an infiltrative growth pattern. CLICK TO VIEW
CR1245 Colorectal Cancer ADC Adenocarcinoma of right lung, moderately differentiated (mixed type, include acinic cell adenocarcinoma and mucinous adenocarcinoma.) Pathology QC: Moderately differentiated adenocarcinoma (P0); Poorly differentiated squamous cell carcinoma (P2). CLICK TO VIEW
CR1281 Colorectal Cancer ADC Metastatic adenocarcinoma of righ lung, poorly differentiated, tumor mass: 2cm x 1.8cm x 1.5cm, malignant cells invaded visceral pleura. CLICK TO VIEW
CR1287 Colorectal Cancer ADC Metastatic colonic adenocarcinoma to liver. The neoplastic cells are cubical columnar cells with the nuclear atypia and abaundant cytoplasm or mucous cytoplasm. The tumor forms irregular tubular structures and has an infiltrative growth pattern. Peripheral hepatic tissues have normal hepatic lobular structures with mild lymphocyte infiltrating portal area. CLICK TO VIEW
CR1305 Colorectal Cancer ADC Metastatic adenocarcinoma to lung, consider rectal carcinoma on basis of medical history. CLICK TO VIEW
CR1400 Colorectal Cancer ADC, Mucinous Villous-tubular adenoma of sigmoid with lower grade intraepithelial neoplasia. CLICK TO VIEW
CR1428 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of sigmoid with hepatic metastases. Tumor cells show columnar with the nuclear atypia. The tumor forms tubular and cribriform structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (2/28). CLICK TO VIEW
CR1451 Colorectal Cancer ADC Metastatic adenocarcinoma to greater omentum. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. CLICK TO VIEW
CR1489 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum. The neoplastic cells are column or cube and are associated with a certain mitotic count. The tumor forms glandular and nest structures toghter with pools of mucin in it and has an infiltrative growth pattern. Mild of signed ring cell are viewed. CLICK TO VIEW
CR14931 Colorectal Cancer NA NA CLICK TO VIEW
CR14939 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15091 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15134 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1519 Colorectal Cancer ADC Poorly differentiated adenocarcinoma CLICK TO VIEW
CR1520 Colorectal Cancer ADC Moderately-poorly differentiated adenocarcinoma CLICK TO VIEW
CR15287 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1530 Colorectal Cancer ADC Moderately differentiated adenocarcinoma CLICK TO VIEW
CR15303 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15339 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15449 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1554 Colorectal Cancer ADC Adenocarcinoma of rectum, ulcerative type, moderately differentiated, invade muscle layer to rectal adventitia, tumor mass: 5cm x 5cm x 2cm. No malignant cells adjacent to superior and inferior stump. Mesenteric LN (0/7). CLICK TO VIEW
CR1559 Colorectal Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
CR1560 Colorectal Cancer ADC Poorly differentiated adenocarcinoma CLICK TO VIEW
CR1563 Colorectal Cancer ADC Adenocarcinoma of rectum, ulcerative type, moderately differentiated, invaded peripheric adipose tissue. No malignant cells adjacent to both stump. Reginol LN: surrounding intestin LN (0/4). CLICK TO VIEW
CR15630 Colorectal Cancer NA NA CLICK TO VIEW
CR1564 Colorectal Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
CR15700 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15701 Colorectal Cancer NA NA CLICK TO VIEW
CR15724 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15726 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1574 Colorectal Cancer ADC Mucinous adenocarcinoma CLICK TO VIEW
CR15765 Colorectal Cancer ADC N/A CLICK TO VIEW
CR15770 Colorectal Cancer NA NA CLICK TO VIEW
CR15788 Colorectal Cancer ADC N/A CLICK TO VIEW
CR1634 Colorectal Cancer ADC Well differentiated adenocarcinoma CLICK TO VIEW
CR1742 Colorectal Cancer ADC, Mucinous Mucinous adenocarcinoma CLICK TO VIEW
CR1744 Colorectal Cancer ADC Moderately differentiated adenocarcinoma CLICK TO VIEW
CR1795 Colorectal Cancer ADC Adenocarcinoma, ulcerative type, moderately-poorly differentiated, invade through intestinal wall to adipose tissue. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/27).IHC results: CK7(-), CK20(+), EGFR(++), P53(+), Ki-67(80%+), Villin(+++), CerbB-2(+), OCT3/4(-). CLICK TO VIEW
CR1801 Colorectal Cancer ADC Adenocarcinoma of duodenal papilla, tumor invade pancreas and surrounding soft tissue. Regional LN: the 12th LN: 0/1. CLICK TO VIEW
CR2037 Colorectal Cancer ADC Adenocarcinoma, NOS CLICK TO VIEW
CR2046 Colorectal Cancer ADC Adenocarcinoma, NOS CLICK TO VIEW
CR2054 Colorectal Cancer ADC, mucinous mucinous adenocarcinoma CLICK TO VIEW
CR2060 Colorectal Cancer ADC Adenocarcinoma, NOS CLICK TO VIEW
CR2069 Colorectal Cancer NA Colon (liver mets) CLICK TO VIEW
CR2072 Colorectal Cancer NA Liver Tissue Mets from Rectum CLICK TO VIEW
CR2073 Colorectal Cancer NA Sigmoid Colon (Intramucosal Carcinoma) CLICK TO VIEW
CR2079 Colorectal Cancer NA Lung Mets from Colorectal Adeno Carcinoma CLICK TO VIEW
CR2083 Colorectal Cancer ADC Sigmoid Colon Adenocarcinoma CLICK TO VIEW
CR2084 Colorectal Cancer ADC Liver Mets from Colon Adenocarcinoma CLICK TO VIEW
CR2110 Colorectal Cancer ADC Adenocarcinoma in sigmoid colon, moderately-poorly differentiated, ulcerative type, invade serosa and adhere small intestine, tumor mass: 6cm x 4cm. No malignant cells adjacent to superior and inferior stump. Regional LN: peri-colon LN (0/16), peri-small intestine LN (0/4). CLICK TO VIEW
CR2161 Colorectal Cancer ADC Moderately adenocarcinoma of colon, with part of mucous adenocarcinoma, ulcerative type, tumor mass: 6.0 x 4.0cm. The tumor invade through intestinal wall but not to intestinal serosa. Regional LN: paraintestinal LN (2/19), omental LN (0/1), LN of superior and root mesenteric artery (0/2), LN of middle colic artery (0/1). IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+25-50%), MLH1(-), MMP7(+<25%), MSH2(+<25%), MSH6(+>75%), P170(+), P27(+<25%), P53(+<25%), TOPOII(+<25%). CLICK TO VIEW
CR2178 Colorectal Cancer ADC Rectal carcinoma CLICK TO VIEW
CR2179 Colorectal Cancer ADC Adenocarcinoma CLICK TO VIEW
CR2226 Colorectal Cancer ADC, mucinous adenocarcinoma Mucinous adenocarcinoma of colon, protruded type, with part of moderately differentiated adenocarcinoma, tumor mass: 6.5cm x 3.5cm. Malignant cells invade peripheral adipose tissue. Regional LN: paraintestinal LN (3/47), LN of ligamentum hepatoduodenale (0/1), LN of porta hepatis (0/5). IHC results: CD44(+), cMet(-), COX2(+), EGFR(-), HER2(1+), Ki67(+25-50%), MLH1(+50-75%), MMP7(weak +), MSH2(+<25%), MSH6(+50-75%), P170(+), P27(+<25%), P53(-), TOPOII(-). CLICK TO VIEW
CR2229 Colorectal Cancer ADC Rectal adenocarcinoma,moderately differentiated. CLICK TO VIEW
CR2241 Colorectal Cancer ADC, mucinous adenocarcinoma Mucinous adenocarcinoma of rectum, ulcerative type, tumor mass: 4.0cm x 3.5cm. The tumor invade through intestinal wall. Cancer embolus in vessel may be seen. Regional LN: 5/10. IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), Hep(-), HER2(-), Ki-67(-), MLH1(>75%+), MMP7(+), MSH2(25~50%+), MSH6(>75%+), P170(+), P27(25~50%+), P53(-), TOPOII(<25%+). CLICK TO VIEW
CR2244 Colorectal Cancer NA Sigmoid colon: moderately differentiated adenocarcinoma. CLICK TO VIEW
CR2258 Colorectal Cancer ADC Invasion adenocarcinoma of sigmoid, poorly differentiated. CLICK TO VIEW
CR2305 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of sigmoid colon. CLICK TO VIEW
CR2327 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR2394 Colorectal Cancer NA Sigmoid colon: carcinoma of sigmoid, metastases to liver and ovary. EGFR partial positive, Her2(-). CLICK TO VIEW
CR2408 Colorectal Cancer ADC Adenocarcinoma, stage IV CLICK TO VIEW
CR2412 Colorectal Cancer NA Mucinous Carcinoma CLICK TO VIEW
CR2441 Colorectal Cancer NA Sigmoid colon: carcinoma of sigmoid, metastases to liver and ovary. CLICK TO VIEW
CR2491 Colorectal Cancer NA Rectum: moderately differentiated adenocarcinoma, ulcerative type. Tumor infiltrated through intestinal wall to serosa and the serosa of uterine wall, metastatic tumor foci could be seen in liver. Six of thirty lymph nodes involved by metastatic carcinoma (6/30). CLICK TO VIEW
CR2501 Colorectal Cancer ADC Moderately differentiated adenocarcinoma CLICK TO VIEW
CR2502 Colorectal Cancer ADC Adenocarcinoma of colon, protruded type, poorly differentiated, invaded peripheral adipose tissue. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (5/17). IHC results: Syn(-), CHgA(-), NSE(-), CK7(-), CK20(++), Villin(+), CA199(++), CEA(++), P53(+), Ki67(80%+). CLICK TO VIEW
CR2506 Colorectal Cancer ADC, mucinous adenocarcinoma Adenocarcinoma from junction of rectum and sigmoid, moderately differentiated. Regional LN: paraintestinal LN (0/10). IHC results: CK(-), CK20(-). CLICK TO VIEW
CR2508 Colorectal Cancer ADC Adenocarcinoma of colon, ulcerative type, moderately differentiated, malignant cell infiltrating through intestinal wall to adipose tissue. Regional LN: mesenteric LN of colon (3/7), mesenteric LN of ileum (0/1). IHC results: CK20(+++), CK7(-), P53(+++), Ki-67(60%+), CEA(+), CA199(+). Chronic appendicitis. CLICK TO VIEW
CR2516 Colorectal Cancer ADC Mucinous adenocarcinoma of colon, poorly differentiated, with part of signet ring cell carcinoma. Metastatic tumor foci to peritoneum may be seen. Regional LN: peripheral LN (13/26). IHC results: CK7(-), CK20(++), Ki67(70%+), CerbB-2(+/-). Special stain: PAS-AB(+). CLICK TO VIEW
CR2517 Colorectal Cancer ADC Adenocarcinoma of sigmoid colon, ulcerative type, moderately differentiated, invaded through intestinal wall. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (1/19). IHC results: CD44(+), Cmet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+50-75%), MLH1(+>75%), MMP7(+), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+<25%), P53(+>75%), TOPOII(+50-75%). CLICK TO VIEW
CR2518 Colorectal Cancer ADC Adenocarcinoma of ascending colon, ulcerative type, poorly differentiated, invade through intestinal wall to peripheric adipose tissue. No malignant cells adjacent to superior and inferior stump. Regional LN: paraintestinal LN (0/17). IHC results: CK7(+/-), CK20(++), Syn(+++), CD56(-), Ki-67(60%+), CerbB-2(-), VEGF(-), D2-40(lymphatic vessel +). CLICK TO VIEW
CR2519 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum, ulcerative type, tumor mass: 3.0 x 2.5cm. The tumor invade through intestinal wall to peripheral intestinal adipose tissue (T3). Regional LN: paraintestinal LN 4/13. IHC results: CD44(+), cMet(+), COX2(+), EGFR(+), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(weak +<25%), MSH2(-), MSH6(+>75%), P170(+), P27(+), P53(-), TOPOII(+<25%). CLICK TO VIEW
CR2520 Colorectal Cancer ADC Adenocarcinoma of colon, protruded ulcerative type, moderately differentiated, invaded through intestinal wall. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/26). IHC results:CD44(+), Cmet(+), COX2(+), EGFR(+), HER2(1+), Ki-67(+>75%), MLH1(-), MMP7(+), MSH2(+50-75%), MSH6(+>75%), P170(+), P27(+<25%), P53(+<25%), TOPOII(+<25%). CLICK TO VIEW
CR2521 Colorectal Cancer ADC Well to moderately differentiated adenocarcinoma of sigmoid colon, protruded type, tumor mass: 5.0 x 4.0 x 0.8cm. Tumor invades intestinal wall to subserosa fibrous tissue. Regional LN: paraintestinal LN (0/19). IHC results: CD44(+++), cMet(+++), COX2(+), EGFR(+), HER2(2+), Ki-67(+>75%), MLH1(+>75%), MMP7(-), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+50~75%), P53(-), TOPOII(+50~75%). Vascular Invasion:neg. Infection Screening (HBV/HCV/HIV/TP):neg. CLICK TO VIEW
CR2523 Colorectal Cancer ADC Rectal adenocarcinoma,ulcerative type, moderate differentiated, tumor mass: 5 x 4cm, invasive through all intestinal wall. IHC results: CD44(+), cMET(+), COX2(+), EGFR(+), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(+), MSH2(+>75%), MSH6(+>75%), P170(+), P27(+50-75%), P53(+>75%), TOPOII(+50-75%). Vascular Invasion: neg. Infection Screening(HBV/HCV/HIV/TP): neg. Regional LN: paraintestinal LN (0/20). CLICK TO VIEW
CR2524 Colorectal Cancer ADC Tubular adenocarcinoma of colon, ulcerative type, moderately differentiated, diameter: 4cm,invaded adipose tissue external serosa. No malignant cells adjacent to both stump. Reginol LN: paraintestinal LN (0/20). CLICK TO VIEW
CR2525 Colorectal Cancer ADC N/A CLICK TO VIEW
CR2526 Colorectal Cancer ADC Moderately adenocarcinoma of sigmoid colon, ulcerative type, tumor mass: 3 x 3cm. The tumor invade through intestinal wall to peripheral adipose tissue. Regional LN: paraintestinal LN 8/23, root of mesenteric LN 0/2. IHC results: CD44(+), cMet(+), COX2(-), EGFR(-), HER2(-), Ki-67(+>75%), MLH1(+>75%), MMP7(-), MSH2(+>75%), MSH6(+>75%), P170(-), P27(+25~50%), P53(-), TOPOII(+>75%). CLICK TO VIEW
CR2528 Colorectal Cancer ADC Tubular adenocarcinoma of ascending colon, moderately differentiated, ulcerative type, tumor mass: 4.5cm x 4cm x 0.8cm. Regional LN: mesenteric LN (0/20). CLICK TO VIEW
CR2530 Colorectal Cancer ADC, mucinous adenocarcinoma Adenocarcinoma of rectum, moderately differentiated, protruded type. Regional LN: mesenteric LN (0/21). IHC results: P53(+), Ki67(80%+), CK7(-), CK20(+++), Villin(+++), CA199(+). CLICK TO VIEW
CR2531 Colorectal Cancer Mucinous adenocarcinoma Adenocarcinoma of colon, moderately differentiated, protruded type, with part of mucinous adenocarcinoma. The tumor invade through intestinal wall to peripheral adipose tissue. Regional LN: Three of thirty lymph node involved by metastatic carcinoma (3/30). IHC results: CK7(-), CK20(++), Villin(++), P53(++), Ki-67(80%+), EGFR(+). CLICK TO VIEW
CR2533 Colorectal Cancer ADC Adenocarcinoma of rectum, moderately differentiated, ulceratived type, tumor mass: 6 x 4cm. The tumor invade through intestinal wall. Regional LN: paraintestinal LN (0/14). IHC results: CD44(+), cMet(+), COX2(+), EGFR(focal +), HER2(3+), Ki-67(+25-50%), MLH1(+>75%),MMP7(-),MSH2(+50-75%),MSH6(+>75%),P170(+),P27(+50-75%),P53(-),TOPOII(+25-50%). Vascular Invasion:neg;Infection Screening (HBV/HCV/HIV/TP):neg. CLICK TO VIEW
CR2545 Colorectal Cancer ADC Adenocarcinoma of ascending colon, ulcerative type, poorly differentiated, invade through intestinal wall to peripheric adipose tissue. No malignant cells adjacent to superior and inferior stump. Regional LN: paraintestinal LN (0/17). IHC results: CK7(+/-), CK20(++), Syn(+++), CD56(-), Ki-67(60%+), CerbB-2(-), VEGF(-), D2-40(lymphatic vessel +). CLICK TO VIEW
CR2554 Colorectal Cancer NA Lung Met from Colon ADC CLICK TO VIEW
CR2556 Colorectal Cancer NA Small Bowel (Jejunum) ADC CLICK TO VIEW
CR2558 Colorectal Cancer ADC N/A CLICK TO VIEW
CR2559 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR2560 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR2564 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR2565 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR2568 Colorectal Cancer ADC N/A CLICK TO VIEW
CR2627 Colorectal Cancer NA Rectal Adenocarcinoma CLICK TO VIEW
CR2814 Colorectal Cancer NA Hepatic metastasis of clonic carcinoma CLICK TO VIEW
CR2822 Colorectal Cancer NA Hepatic metastasis of clonic carcinoma CLICK TO VIEW
CR2828 Colorectal Cancer NA NA CLICK TO VIEW
CR2831 Colorectal Cancer NA Hepatic metastasis of clonic carcinoma CLICK TO VIEW
CR2832 Colorectal Cancer ADC N/A CLICK TO VIEW
CR2837 Colorectal Cancer ADC N/A CLICK TO VIEW
CR2848 Colorectal Cancer NA NA CLICK TO VIEW
CR2849 Colorectal Cancer NA NA CLICK TO VIEW
CR2856 Colorectal Cancer NA NA CLICK TO VIEW
CR2857 Colorectal Cancer NA NA CLICK TO VIEW
CR2864 Colorectal Cancer NA NA CLICK TO VIEW
CR3015 Colorectal Cancer ADC Adenocarcinoma of sigmoid colon, moderately differentiated. Regional LN: mesenteric LN (4/16). CLICK TO VIEW
CR3056 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum CLICK TO VIEW
CR3077 Colorectal Cancer ADC Serous adenocarcinoma of right ovary with necrosis, grade II. The malignant cell may be seen in the node of left uterus. CLICK TO VIEW
CR3078 Colorectal Cancer ADC 1. Moderately differentiated adenocarcinoma of colon. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (2/11). 2. Metastatic adenocarcinoma to liver CLICK TO VIEW
CR3079 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum, invasive growth. Regional LN: external rectal LN (5/14). CLICK TO VIEW
CR3085 Colorectal Cancer ADC Poorly differentiated adenocarcinoma of right colon. Tumor cells show columnar with rotundity and oval nuclear. Tubular and streak tumors are seen, toghter with invasive growth. Regional LN: mesenteric LN (5/18). CLICK TO VIEW
CR3099 Colorectal Cancer ADC Pathology QC: Moderately differentiated adenocarcinoma (P2). CLICK TO VIEW
CR3101 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of transverse colon with hepatic metastases. The tumor forms tubular, nesting and papillary structures and has an infiltrative growth pattern. Regional LN: mesenteric LN (13/37). Chronic appendicitis. Chronic cholecystitis. CLICK TO VIEW
CR3105 Colorectal Cancer ADC 1. Metastatic or invasive adenocarcinoma of bilateral ovary with massive necrosis, grade II. 2. Adenocarcinoma of colon, grade II, protruded type. Regional LN: paraileac LN (0/5), paracolonic LN (0/4), NO.6 LN (0/1), paracaecal LN (2/15). CLICK TO VIEW
CR3107 Colorectal Cancer ADC Metastatic adenocarcinoma to liver, consider rectal adenocarcinoma on basis of medical history. The tumor forms tubular structures. Tumor cells show tall column with pleomorphism, prominent nucleoli. CLICK TO VIEW
CR3114 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of ascending colon. The tumor forms glandular or cribriform structures and has an infiltratived growth pattern. Regional LN: mesenteric LN (2/15). Mixed hyperplastic adenomatous polyp. Chronic appendicitis. CLICK TO VIEW
CR3150 Colorectal Cancer ADC, mucinous adenocarcinoma Adenocarcinoma of colon with part of mucinous adenocarcinoma, moderately differentiated. Tumor cells show columnar with circular or oval nuclear. The tumor forms tubular or nest structures and has an infiltrative growth pattern. Poors of mucin in glandular cavity may be seen. Regional LN: mesenteric LN (5/20). CLICK TO VIEW
CR3151 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of transverse colon. The tumor forms cribriform, glandular structures and has an infiltrative growth pattern. Regional LN: mesnteric LN (4/12). Gastrointestinal stromal tumor of Meckel's diverticulum. CLICK TO VIEW
CR3157 Colorectal Cancer ADC, mucinous adenocarcinoma Moderately differentiated adenocarcinoma of rectum. The tumor forms irregular glandular or cribriform structures and has an infiltrative growth pattern. Mucous secretiona may be seen. Regional LN: rectal LN (4/11). CLICK TO VIEW
CR3211 Colorectal Cancer Adenocarcinoma Transverse colon: moderately differentiated adenocarcinoma. Two of ninteen lymph nodes involved by metastatic carcinoma (2/19) CLICK TO VIEW
CR3235 Colorectal Cancer ADC, mucinous adenocarcinoma NA for clinical diagnosis info. CLICK TO VIEW
CR3253 Colorectal Cancer ADC Ascending colon: moderately differentiated adenocarcinoma CLICK TO VIEW
CR3262 Colorectal Cancer ADC Rectum: moderately differentiated adenocarcinoma. The tumor infiltated through intestinal wall to subserosa. Six out of fifteen lynph nodes showed metastatic adenocarcinoma. CLICK TO VIEW
CR3278 Colorectal Cancer Mucinous adenocarcinoma Moderately differentiated adenocarcinoma, with part of mucinous adenocarcinoma CLICK TO VIEW
CR3279 Colorectal Cancer ADC ADC with mucinous adenocarcinoma CLICK TO VIEW
CR3280 Colorectal Cancer ADC Rectum: moderately differentiated adenocarcinoma with mucinous adenocarcinoma component. Five of fifteen lymph nodes involved by metastatic carcinoma (5/15). CLICK TO VIEW
CR3300 Colorectal Cancer ADC, mucinous adenocarcinoma Moderately differentiated adenocarcinoma, with part of mucinous adenocarcinoma CLICK TO VIEW
CR3310 Colorectal Cancer ADC Adenocarcinoma of sigmoid, grade II-III, infiltrating to serosa. Five of thirteen lymph nodes involved by metastatic carcinoma (5/13). CLICK TO VIEW
CR3311 Colorectal Cancer ADC Sigmoid colon: adenocarcinoma, grade II-III, infiltrating to serosa. Five of thirteen lymph nodes involved by metastatic carcinoma (5/13). CLICK TO VIEW
CR3315 Colorectal Cancer ADC Ascending colon: moderately differentiated adenocarcinoma, infiltrating to serosa. Three of twenty lymph nodes involved by metastatic carcinoma (3/20). CLICK TO VIEW
CR3344 Colorectal Cancer ADC Rectum: poorly differentiated adenocarcinoma CLICK TO VIEW
CR3348 Colorectal Cancer ADC, mucinous adenocarcinoma Ileocecal junction: moderately differentiated adenocarcinoma with mucinous adenocarcinoma component. Four of twenty-three lymph nodes involved by metastatic carcinoma (4/23). CLICK TO VIEW
CR3398 Colorectal Cancer ADC Sigmoid: adenocarcinoma, grade II, stage pT3N2Mx, infiltrating to serosa. Nine of fifteen lymph nodes involved by metastatic carcinoma (9/15) CLICK TO VIEW
CR3403 Colorectal Cancer ADC Rectal adenocarcinoma, grade II. The tumor infiltrated deep muscularis. There are multiple regional lymph nodes metastases. 21 out of 35 lymph nodes show metastatic adenocarcinoma. CLICK TO VIEW
CR3406 Colorectal Cancer ADC N/A CLICK TO VIEW
CR3424 Colorectal Cancer ADC Colon: adenocarcinoma, moderately differentiated, infiltrating to subserosa. CLICK TO VIEW
CR3444 Colorectal Cancer ADC Duodenum: moderately differentiated adenocarcinoma with metastasis to lymph nodes surrounding pancreas CLICK TO VIEW
CR3448 Colorectal Cancer ADC Metastatic adenocarcinoma from liver, consider colorectal carcinoma based on morphology and medical history. CLICK TO VIEW
CR3469 Colorectal Cancer ADC Adenocarcinoma of colon, grade II, infiltrating to serosa and omentum majus. Two of twenty-three lymph nodes involved by metastatic carcinoma (2/23). CLICK TO VIEW
CR3485 Colorectal Cancer ADC Rectum: adenocarcinoma, grade II-III, infiltrating adipose tissue surrounding intestine, metastasis to liver. Three of fourteen lymph nodes involved by metastatic carcinoma (3/14) CLICK TO VIEW
CR3486 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR3496 Colorectal Cancer ADC Colon, ileocecal junction: adenocarcinoma, grade II-III, infiltrating to serosa. One of sixteen lymph nodes involved by metastatic carcinoma (1/16). CLICK TO VIEW
CR3547 Colorectal Cancer NA Metastatic mucinous adenocarcinoma from tissue surrounding umbilical opening CLICK TO VIEW
CR3565 Colorectal Cancer ADC Ileocecal junction: adenocarcinoma, grade II, infiltrating to peri-intestinal adipose tissue, metastasis to liver. CLICK TO VIEW
CR3566 Colorectal Cancer ADC Colorectal Cancer, adenocarcinoma. CLICK TO VIEW
CR3586 Colorectal Cancer NA NA CLICK TO VIEW
CR3592 Colorectal Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
CR3594 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR3595 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR3612 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR3803 Colorectal Cancer NA NA CLICK TO VIEW
CR3804 Colorectal Cancer ADC NA for clinical diagnosis info. CLICK TO VIEW
CR3808 Colorectal Cancer Adenocarcinoma N/A CLICK TO VIEW
CR3811 Colorectal Cancer Adenocarcinoma N/A CLICK TO VIEW
CR3814 Colorectal Cancer NA NA CLICK TO VIEW
CR3819 Colorectal Cancer adenocarcinoma NA CLICK TO VIEW
CR3820 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR3825 Colorectal Cancer Adenocarcinoma N/A CLICK TO VIEW
CR5026 Colorectal Cancer ADC adenocarcinoma, metastatic, pd CLICK TO VIEW
CR5027 Colorectal Cancer NA recurrent colon carcinoma. Pathol comment: c/w referring diagnosis. approximately 30% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep. CLICK TO VIEW
CR5028 Colorectal Cancer ADC colon carcinoma adenocarcinoma. Pathol comment: c/w referring diagnosis. approximately 30% of the tissue involved by tumor in sections examined. tumor cells present in cytospin prep. CLICK TO VIEW
CR5029 Colorectal Cancer ADC colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5030 Colorectal Cancer ADC colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approx. 60% of the tissue involved by malignant tumor in sections examined. 30% necrosis. rare tumor cells present in cytospin prep. CLICK TO VIEW
CR5032 Colorectal Cancer ADC colon carcinom ametastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep.necro CLICK TO VIEW
CR5033 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5038 Colorectal Cancer ADC metastatic colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5039 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5040 Colorectal Cancer ADC colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5043 Colorectal Cancer ADC metastatic colon carcinoma adenocarcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5044 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5046 Colorectal Cancer ADC colon carcinomametastatic rectal adenocarcinoma. Pathol comment: c/w diagnosis. approximately 75% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5048 Colorectal Cancer ADC colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5052 Colorectal Cancer ADC colon carcinoma metastatic adenocarcinoma c/w colon primary. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5053 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5055 Colorectal Cancer NA colon carcinoma metastatic colon cancer. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5058 Colorectal Cancer ADC colon carcino mametastatic colonic adenocarcinoma. Pathol comment: c/w referring diagnosis. microscopic focus of malignant tumor present in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5059 Colorectal Cancer ADC colon carcinoma metastatic adenocarcinoma, pd. Pathol comment: c/w diagnosis. approximately 60% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5062 Colorectal Cancer NA R Colon Carcinoma. Pathol comment: c/w diagnosis. Approx. 40% of the tissue involved by malignant tumor in sectionss examined. 20% necrotic malignant tumor cells in cytospin prep. CLICK TO VIEW
CR5063 Colorectal Cancer Signet ring cell carcinoma colon carcinoma signet ring cell carcinoma. Pathol comment: c/w referring diagnosis. malignant tumor cells present in cell block and cytospin prep. CLICK TO VIEW
CR5066 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 20% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5067 Colorectal Cancer ADC colon cancer metastatic adenocarcinoma. Pathol comment: c/w diagnosis. approximately 50% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5072 Colorectal Cancer Mucinous adenocarcinoma colon carcinoma mucinous adenocarcinoma, g2, md. Pathol comment: c/w diagnosis. approximately 10% of the detached tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5073 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 10% necrotic. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5074 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 40% of the tissue involved by malignant tumor in sections examined. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5075 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 100% of the tissue involved by malignant tumor in sections examined. 30% necrotic. malignant tumor cells present in cytospin prep. CLICK TO VIEW
CR5079 Colorectal Cancer ADC N/A CLICK TO VIEW
CR5080 Colorectal Cancer ADC colon carcinoma metastatic colon adenocarcinoma. Pathol comment: c/w diagnosis. approximately 80% of the tissue involved by malignant tumor in sections examined. 95% necrosis. approximately 30% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5081 Colorectal Cancer NA rectal carcinoma metastatic carcinoma. Pathol comment: c/w diagnosis. microscopic focus of malignant tumor present in tissue sections examined. focal tumor necrosis. c/w adenocarcinoma. approximately 20% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5082 Colorectal Cancer NA rectal cancer metastatic anaplastic malignant epithelial cells. Pathol comment: malignant tumor cells present in cell block. approximately 70% malignant tumor cells present in cytospin preparation. c/w diagnosis. CLICK TO VIEW
CR5083 Colorectal Cancer ADC colon carcinoma adenocarcinoma, grade ii, c/w metastatic colon carcinoma. Pathol comment: c/w diagnosis. approximately 90% of the tissue involved by malignant tumor in sections examined. 40% necrosis. approximately 50% malignant tumor cells present in cytospin preparation. extracellular mucin and necrosis are present. CLICK TO VIEW
CR5084 Colorectal Cancer NA colon carcinoma and adenocarcinoma showing neuroendocrine features. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 60% malignant tumor cells present in cytospin preparation. abundant extracellular mucin present. CLICK TO VIEW
CR5085 Colorectal Cancer NA colon carcinoma. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. approximately 10% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5087 Colorectal Cancer NA colon carcinoma carcinoma. Pathol comment: c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. focal tumor necrosis. approximately 20% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5088 Colorectal Cancer NA Colon carcinoma. Pathol comment: c/w with diagnosis. Approximately 70% of the tissue involved by malignant tumor in sections examined. Focal tumor necrosis. Approximately 70% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5090 Colorectal Cancer NA colon carcinoma. Pathol comment: no viable tumor present in tissue sections examined. extensive necrosis. approximately 60% malignant tumor cells present in cytospin preparation. c/w diagnosis. CLICK TO VIEW
CR5091 Colorectal Cancer NA colon carcinoma poorly differentiated carcinoma. Pathol comment: c/w diagnosis. approximately 70% of the tissue involved by malignant tumor in sections examined. 30% necrosis. approximately 50% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5092 Colorectal Cancer NA colon carcinoma. Pathol comment: malignant tumor cells present in cell block. approximately 10% malignant tumor cells present in cytospin preparation. c/w diagnosis. CLICK TO VIEW
CR5093 Colorectal Cancer NA colon carcinoma carcinoma. Pathol comment: approximately 60% of the tissue involved by malignant tumor in sections examined. 5% necrosis. c/w adenocarcinoma. approximately 80% malignant tumor cells present in cytospin preparation. CLICK TO VIEW
CR5095 Colorectal Cancer Colon (BRAF mut) Colon carcinoma. Pathol comment:c/w diagnosis. approximately 10% of the tissue involved by malignant tumor in sections examined. approximately 40% malignant tumor cells present in cytospin preparation. abundant extracellular mucin. Abundant extracellular mucin. CLICK TO VIEW
CR5098 Colorectal Cancer ADC colon carcinoma moderately differentiated adenocarcinoma c/w colonic primary. CLICK TO VIEW
CR5100 Colorectal Cancer NA colon carcinoma. CLICK TO VIEW
CR5101 Colorectal Cancer ADC colon carcinoma metastatic colonic adenocarcinoma. CLICK TO VIEW
CR5103 Colorectal Cancer ADC colonic adenocarcinoma grade 2. figo iv. CLICK TO VIEW
CR6217 Colorectal Cancer ADC Adenocarcinoma of sigmoid, infiltrating through intestinal wall to adipose tissue. Two of twelve lymph nodes involoved by metastatic carcinoma (2/12) CLICK TO VIEW
CR6218 Colorectal Cancer ADC Tubular adenocarcinoma of sigmoid colon, grade II, infiltrating through intestinal wall to adipose tissue. One of twelve lymph nodes involoved by metastatic carcinoma (1/12) CLICK TO VIEW
CR6219 Colorectal Cancer ADC Tubular adenocarcinoma of sigmoid colon, grade II CLICK TO VIEW
CR6221 Colorectal Cancer ADC Tubular adenocarcinoma of juncture of sigmoid colon and rectum, grade II, infiltrating to superficial muscularis. All lymph nodes are benign (0/12). CLICK TO VIEW
CR6222 Colorectal Cancer ADC Adenocarcinoma of rectum, grade II, infiltrating to pericolonal adipose tissue. One of fifteen lymph nodes involved by metastatic carcinoma (1/15). CLICK TO VIEW
CR6223 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum, infiltrating to intestinal surrounding fibrofatty tissue. All lymph nodes are benign (0/12). CLICK TO VIEW
CR6224 Colorectal Cancer ADC Adenocarcinoma of sigmoid colon, grade II, infiltrating to intestinal surrounding fibrofatty tissue. Five of fourteen lymph nodes involved by metastatic carcinoma (5/14). CLICK TO VIEW
CR6225 Colorectal Cancer ADC Tubular adenocarcinoma of colon, with mucinous adenocarcinoma component. Tumor invaded to subserosal fat tissue, no lymph nodes involved by metastatic carcinoma (0/12). CLICK TO VIEW
CR6226 Colorectal Cancer ADC Moderately differentiated adenocarcinoma, with mucinous adenocarcinoma component. Tumor invaded to serosa, four of twenty-five lymph nodes involved by metastatic carcinoma (4/25). CLICK TO VIEW
CR6227 Colorectal Cancer ADC Moderately to poorly differentiated adenocarcinoma of rectum, infiltrating to intestinal adventitia. Three of twenty-one lymph nodes involved by metastatic carcinoma (3/21). CLICK TO VIEW
CR6229 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of head of pancreas, infiltrating to common bile duct. One of nine lymph nodes involved by metastatic carcinoma (1/9). CLICK TO VIEW
CR6234 Colorectal Cancer ADC, tubular Colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to subserosal fat tissue. CLICK TO VIEW
CR6235 Colorectal Cancer ADC Transverse colon: adenocarcinoma, grade II, infiltrating to serosa. Six of twenty-five lymph nodes involved by metastatic carcinoma (6/25). CLICK TO VIEW
CR6241 Colorectal Cancer ADC Tubular adenocarcinoma of transverse colon, moderately differentiated, infiltrating to serosa. CLICK TO VIEW
CR6242 Colorectal Cancer ADC Tubular adenocarcinoma of rectum, grade II, infiltrating to superficial muscularis. All lymph nodes are benign (0/14). CLICK TO VIEW
CR6243 Colorectal Cancer ADC Papillary, tubular adenocarcinoma of ileocecal junction, grade II, infiltrating to serosa. One of twelve lymph nodes involved by metastatic carcinoma (1/12). CLICK TO VIEW
CR6244 Colorectal Cancer ADC Adenocarcinoma of rectum, grade II. Tumor invaded surrounding fatty tissue. All lymph nodes are benign (0/11). CLICK TO VIEW
CR6248 Colorectal Cancer ADC Tubular adenocarcinoma of sigmoid, grade II, infiltrating to subserosal fat tissue. CLICK TO VIEW
CR6249 Colorectal Cancer ADC Ileocecal junction: moderately-poorly differentiated adenocarcinoma, with musinous adenocarcinoma component. Tumor invade through intestinal wall to fibrofatty tissue. One of seven lymph nodes involved by metastatic carcinoma. CLICK TO VIEW
CR6250 Colorectal Cancer ADC Tubular adenocarcinoma of colon, grade II, stage pT3N0Mx. All lymph nodes are benign (0/11). CLICK TO VIEW
CR6251 Colorectal Cancer ADC Adenocarcinoma of rectum, grade II. Tumor invaded deep muscularis CLICK TO VIEW
CR6252 Colorectal Cancer ADC Transverse colon: papillary, tubular adenocarcinoma, grade II. Tumor invaded through intestinal wall to fibrofatty tissue, all lymph nodes are benign (0/10). CLICK TO VIEW
CR6253 Colorectal Cancer ADC Adenocarcinoma of colon, grade II-III, stage T3N0M0. Tumor invaded to serosa, all lymph nodes are benign (0/18). CLICK TO VIEW
CR6254 Colorectal Cancer ADC Adenocarcinoma of rectum, moderately differentiated. CLICK TO VIEW
CR6255 Colorectal Cancer ADC Descending colon: adenocarcinoma, grade II, infiltrating to subserosa. All lymph nodes are benign (0/13). CLICK TO VIEW
CR6256 Colorectal Cancer ADC Tubular adenocarcinoma of rectum, grade II. Tumor invaded through intestinal wall to fibrofatty tissue, with metastasis in lymph nodes (3/11) and two carcinomatous nodule formation. CLICK TO VIEW
CR6257 Colorectal Cancer ADC, tubular Ascending colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to serosa. All lymph nodes are benign (0/26). CLICK TO VIEW
CR6267 Colorectal Cancer ADC Moderately differentiated adenocarcinoma of rectum CLICK TO VIEW
CR6269 Colorectal Cancer SCC, Anal canal Anal canal: squamous cell carcinoma, grade II. Metastatic carcinoma involves 7 of 14 lymph nodes and 4 carcniomatous nodule formation. CLICK TO VIEW
CR6286 Colorectal Cancer ADC, tubular Sigmoid colon: moderately differentiated tubular adenocarcinoma, the tumor infiltrated to serosa. Four out of fourteen lymph nodes showed metastatic adenocarcinoma. CLICK TO VIEW
CR6287 Colorectal Cancer Mucinous adenocarcinoma N/A CLICK TO VIEW
CR6289 Colorectal Cancer ADC Tubular adenocarcinoma, grade II CLICK TO VIEW
CR6290 Colorectal Cancer ADC Poorly differentated tubular adenocarcinoma CLICK TO VIEW
CR6309 Colorectal Cancer NA Metastatic colorectal carcinoma to liver CLICK TO VIEW
CR6310 Colorectal Cancer NA Metastatic colorectal carcinoma to liver CLICK TO VIEW
CR6447 Colorectal Cancer ADC Moderate differentiation. CLICK TO VIEW
CR6453 Colorectal Cancer ADC Colorectal mets in segment VIII - complete resection with vascular and bile duct invasion CLICK TO VIEW
CR6454 Colorectal Cancer ADC Liver histology: Metastatic colonic adenocarcinoma, liver mets. CLICK TO VIEW
CR6455 Colorectal Cancer ADC Liver & regional lymph nodes - metastatic colorectal adenocarcinoma. Differentiation: moderate. Post Op survival: 13 months. CLICK TO VIEW
CR6456 Colorectal Cancer ADC Liver histology: Moderately differentiated metastatic adenocarcinoma, liver mets. Past medical history: Lymphoma. CLICK TO VIEW
CR6457 Colorectal Cancer ADC multiple liver mets; tumor size: 7 x 1 & 6 x 2. Post Op survival: 1 year. CLICK TO VIEW
CR6458 Colorectal Cancer NA NA CLICK TO VIEW
CR6460 Colorectal Cancer ADC Liver histology: Hepatic resection for mucinous adenocarcinoma posible intrahepatic spread CLICK TO VIEW
CR6461 Colorectal Cancer ADC metastatic moderately differentiated adenocarcinoma with intrahepatic spread - excision is complete CLICK TO VIEW
CR6620 Colorectal Cancer NA Sigmoid: adenocarcinoma, ulcerative type, grade II, infiltrating through intestinal wall to adipose tissue. CLICK TO VIEW
CR6629 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR6689 Colorectal Cancer ADC Left lobe of liver: adenocarcinoma, grade II. Consider metastatic colon adenocarcinoma in liver on the basis of medical history and IHC results. CLICK TO VIEW
CR6721 Colorectal Cancer ADC Left lobe of liver: adenocarcinoma, grade II-III. Metastatic colonic adenocarcinoma in liver, based on medical history, morphology and IHC results. CLICK TO VIEW
CR6801 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6804 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6805 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6847 Colorectal Cancer NA Sigmoid: poorly differentiated adenocarcinoma, infiltrating to subserosa adipose tissue. CLICK TO VIEW
CR6848 Colorectal Cancer ADC Colon: moderately differentiated adenocarcinoma CLICK TO VIEW
CR6849 Colorectal Cancer ADC Sigmoid colon: moderately differentiated adenocarcinoma. All lymph nodes are benign (0/11). CLICK TO VIEW
CR6852 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6853 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6854 Colorectal Cancer NA Colon: well differentiated adenocarcinoma, infiltrating through serosa to adipose tissue. CLICK TO VIEW
CR6856 Colorectal Cancer NA NA for clinical diagnosis info. CLICK TO VIEW
CR6857 Colorectal Cancer NA Sigmoid: moderately differentiated adenocarcinoma, infiltrating through intestinal wall to adipose tissue. Eight of twenty-five lymph nodes involved by malignant carcinoma (8/25). CLICK TO VIEW
CR6858 Colorectal Cancer NA Colon: moderately differentiated adenocarcinoma, infiltrating through intestinal wall to adipose tissue. CLICK TO VIEW
CR6860 Colorectal Cancer NA Colon: moderately to poorly differentiated adenocarcinoma, infiltrating to adipose tissue. CLICK TO VIEW
CR6861 Colorectal Cancer NA Sigmoid: mucinous adenocarcinoma (90%) with poorly differentiated adenocarcinoma (10%). CLICK TO VIEW
CR6863 Colorectal Cancer ADC Colon: moderately to poorly differentiated adenocarcinoma (60%), with mucinous component (40%), infiltrating to subserosa. Ten of twenty-two lympho nodes involved by malignant carcinoma (10/22). CLICK TO VIEW
CR6909 Colorectal Cancer ADC Metastatic poorly differentiated adenocarcinoma (derived from sigmoid colon) CLICK TO VIEW
CR6924 Colorectal Cancer NA Rectum: moderately differentiated adenocarcinoma, infiltrating to muscular layer. CLICK TO VIEW
CR6925 Colorectal Cancer ADC Rectum: moderately differentiated adenocarcinoma, infiltrating through intestinal wall. All lymph nodes are benign (0/16). CLICK TO VIEW
CR6927 Colorectal Cancer NEC Rectum: small cell neuroendocrine carcinoma (G3), infiltrating through intestinal wall. CLICK TO VIEW
CR9250 Colorectal Cancer NA NA CLICK TO VIEW
CR9252 Colorectal Cancer ADC N/A CLICK TO VIEW
CR9253 Colorectal Cancer ADC, mucinous NA CLICK TO VIEW
CR9255 Colorectal Cancer NA NA CLICK TO VIEW
CR9256 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR9260 Colorectal Cancer NA NA CLICK TO VIEW
CR9263 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR9264 Colorectal Cancer Adenocarcinoma NA CLICK TO VIEW
CR9268 Colorectal Cancer ADC N/A CLICK TO VIEW

Sorry, no posts matched your criteria.

Create Account to View All Model Data

Already Registered? Login